Bank of New York Mellon’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $86.5M | Sell |
|
|||||
|
2021
Q2 | $63.3M | Sell |
|
|||||
|
2021
Q1 | $73.7M | Buy |
|
|||||
|
2020
Q4 | $61.8M | Buy |
|
|||||
|
2020
Q3 | $51.4M | Buy |
|
|||||
|
2020
Q2 | $31.3M | Sell |
|
|||||
|
2020
Q1 | $32.3M | Sell |
|
|||||
|
2019
Q4 | $39.1M | Buy |
|
|||||
|
2019
Q3 | $29.1M | Buy |
|
|||||
|
2019
Q2 | $19.6M | Sell |
|
|||||
|
2019
Q1 | $22.5M | Buy |
|
|||||
|
2018
Q4 | $19.1M | Buy |
|
|||||
|
2018
Q3 | $10.8M | Buy |
|
|||||
|
2018
Q2 | $8.3M | Buy |
|
|||||
|
2018
Q1 | $6.49M | Buy |
|
|||||
|
2017
Q4 | $7M | Sell |
|
|||||
|
2017
Q3 | $6.18M | Buy |
|
|||||
|
2017
Q2 | $4.21M | Buy |
|
|||||
|
2017
Q1 | $3.19M | Sell |
|
|||||
|
2016
Q4 | $3.46M | Buy |
|
|||||
|
2016
Q3 | $4.77M | Sell |
|
|||||
|
2016
Q2 | $4.68M | Buy |
|
|||||
|
2016
Q1 | $3.48M | Buy |
|
|||||
|
2015
Q4 | $5.22M | Buy |
|
|||||
|
2015
Q3 | $2.4M | Buy |
|
|||||
|
2015
Q2 | $2.95M | Buy |
|
|||||
|
2015
Q1 | $2.74M | Buy |
|
|||||
|
2014
Q4 | $2.73M | Buy |
|
|||||
|
2014
Q3 | $2.05M | Buy |
|
|||||
|
2014
Q2 | $2.06M | Buy |
|
|||||
|
2014
Q1 | $1.13M | Buy |
|
|||||
|
2013
Q4 | $886K | Buy |
|